Coeptis Therapeutics, Inc. Capital Units, Authorized
Coeptis Therapeutics, Inc. had Capital Units, Authorized of 760.00 million shares as of 2020-12-31, per its 10-KT filed 2021-05-11.
Discontinued › Notes › Equity
us-gaap:CapitalUnitsAuthorized · last filed 2021-05-11
- 2020-12-31: Capital Units, Authorized 760.00M shares.
- 2020-11-30: Capital Units, Authorized 760.00M shares.
- 2020-08-31: Capital Units, Authorized 760.00M shares.
| Period end | Capital Units, Authorized |
|---|---|
| 2020-12-31 | 760.00M shares 10-KT · filed 2021-05-11 |
| 2020-11-30 | 760.00M shares 10-Q · filed 2021-01-11 |
| 2020-08-31 | 760.00M shares 10-Q/A · filed 2020-11-23 |